Page 3 - Clinical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dive into advanced data, ethical issues at free online event (NatalyaBurova/iStock via Getty Images Plus) The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues. In the face of increasingly complex data, pressures to get therapies to market as rapidly as possible, desire to decrease patient burden, COVID-19-created obstacles, and other challenges, clinical research professionals are under a great deal of pressure. Any technology or tools that empower them to accomplish thei...

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations. Several COVID-19 vaccines have been approved and administered to millions of people around the globe. Since the virus’s arrival, researchers also have been on the hunt for drugs that can effectively battle the disease in patients that receive a positive diagnosis. Berg, a company that uses proprietary artificial intelligence (AI) tech to identify and pursue potential drug candidates, recently used its proprietar...

FDA current COVID-19 updates, actions and advice As the vaccine goes into the arms of more people around the country, the US agency keeps on top of issues around the virus, offering resources and guidance. The phenomenon of "vaccine euphoria" has taken hold in the US, with patients receiving their first or second shots gleefully sharing images on Facebook, Instagram and other social media platforms. Still, because the virus is not over, the US Food and Drug Administration (FDA) continues to act as a resource for medical professionals working on tests, treatments an...

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials. Through this agreement, GSK is looking to improve its GMP cell processing network to advance its early stage pipeline and streamline technical transfer. “The move by a leading pharmaceutical company like GSK to establish ATMP manufacturing capabilities at the CGT Catapult facility i...

Saama, Oracle partner on integrated clinical trial technology Saama’s range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development. Saama Technologies is collaborating with Oracle to integrate Saama’s smart applications with the Oracle Health Sciences Clinical One platform. The collaboration is intended to enable pharmaceutical companies and their research partners to harness artificial intelligence (AI)-driven insights to expedite clinical trials. Saama chief strategy officer Sag...